NDC 69238-1552

Memantine and Donepezil Hydrochlorides Extended-release

Memantine And Donepezil

Memantine and Donepezil Hydrochlorides Extended-release is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Ny Llc. The primary component is Memantine Hydrochloride; Donepezil Hydrochloride.

Product ID69238-1552_397c2949-6b6e-4927-9e98-b0dfda3a5449
NDC69238-1552
Product TypeHuman Prescription Drug
Proprietary NameMemantine and Donepezil Hydrochlorides Extended-release
Generic NameMemantine And Donepezil
Dosage FormCapsule, Extended Release
Route of AdministrationORAL
Marketing Start Date2017-02-01
Marketing CategoryANDA / ANDA
Application NumberANDA208328
Labeler NameAmneal Pharmaceuticals NY LLC
Substance NameMEMANTINE HYDROCHLORIDE; DONEPEZIL HYDROCHLORIDE
Active Ingredient Strength7 mg/1; mg/1
Pharm ClassesNMDA Receptor Antagonists [MoA],N-methyl-D-aspartate Receptor Antagonist [EPC],Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 69238-1552-3

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69238-1552-3)
Marketing Start Date2017-02-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69238-1552-9 [69238155209]

Memantine and Donepezil Hydrochlorides Extended-release CAPSULE, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA208328
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-02-01

NDC 69238-1552-3 [69238155203]

Memantine and Donepezil Hydrochlorides Extended-release CAPSULE, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA208328
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-02-01

Drug Details

Active Ingredients

IngredientStrength
MEMANTINE HYDROCHLORIDE7 mg/1

OpenFDA Data

SPL SET ID:2335950c-be3b-4248-ad04-e9763aee47d2
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1599805
  • 1599803
  • 1805425
  • 1805420
  • UPC Code
  • 0369238124897
  • 0369238155396
  • 0369238124798
  • 0369238155297
  • Pharmacological Class

    • NMDA Receptor Antagonists [MoA]
    • N-methyl-D-aspartate Receptor Antagonist [EPC]
    • Cholinesterase Inhibitor [EPC]
    • Cholinesterase Inhibitors [MoA]
    • NMDA Receptor Antagonists [MoA]
    • N-methyl-D-aspartate Receptor Antagonist [EPC]
    • Cholinesterase Inhibitor [EPC]
    • Cholinesterase Inhibitors [MoA]

    NDC Crossover Matching brand name "Memantine and Donepezil Hydrochlorides Extended-release" or generic name "Memantine And Donepezil"

    NDCBrand NameGeneric Name
    69238-1247Memantine and Donepezil Hydrochlorides Extended-releaseMemantine and Donepezil
    69238-1248Memantine and Donepezil Hydrochlorides Extended-releaseMemantine and Donepezil
    69238-1552Memantine and Donepezil Hydrochlorides Extended-releaseMemantine and Donepezil
    69238-1553Memantine and Donepezil Hydrochlorides Extended-releaseMemantine and Donepezil

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.